Page last updated: 2024-10-22

albuterol and Di Guglielmo Disease

albuterol has been researched along with Di Guglielmo Disease in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beckman, B1
Mirand, E1
Fisher, JW1

Other Studies

1 other study available for albuterol and Di Guglielmo Disease

ArticleYear
Effects of beta adrenergic agents and prostaglandin E1 on erythroid colony (CFU-E) growth and cyclic AMP formation in Friend erythroleukemic cells.
    Journal of cellular physiology, 1980, Volume: 105, Issue:2

    Topics: Adenylyl Cyclases; Albuterol; Animals; Bone Marrow; Cells, Cultured; Cyclic AMP; Erythropoiesis; Fem

1980